Company Filing History:
Years Active: 2010-2014
Title: Innovations by Hidehiro Suzuki
Introduction
Hidehiro Suzuki is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases related to vascular constriction and vasodilation. With a total of 2 patents, his work has the potential to impact various medical conditions.
Latest Patents
One of his latest patents is a pharmaceutical composition for the treatment of diseases due to vascular constriction or vasodilation. This therapeutic agent comprises an EDG-5 modulator, which specifically binds to EDG-5 and exhibits either antagonistic or agonistic action. This invention is particularly useful for treating conditions such as cerebrovascular spasmodic disorder, hypertension, and cardiac infarction. Another significant patent involves a highly active lysophosphatidic acid (LPA) and a method for screening substances that can modulate the binding of LPA with its receptor. This method aims to identify preventive and therapeutic agents for various diseases, including cancer and diabetes.
Career Highlights
Hidehiro Suzuki has worked with prominent companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Throughout his career, Suzuki has collaborated with notable colleagues such as Shinji Nakade and Akio Hayashi. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Hidehiro Suzuki's contributions to medical innovation, particularly through his patents, demonstrate his commitment to advancing healthcare solutions. His work continues to pave the way for new treatments that address critical health issues.